Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 11/08 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 11/08 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
64,18,87,034
Market Cap (USD)
45,02,79,569
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63%
Free-Float capitalization (CAD)
36,34,83,187
Free-Float capitalization (USD)
25,49,81,085
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 45Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -3.11% | -2.32% | +23.28% | +77.03% | 5.93TCr | |
| +0.89% | -0.77% | +5.80% | +32.89% | 4.71TCr | |
| -0.96% | -6.11% | +26.70% | +31.24% | 4.29TCr | |
| +0.36% | +3.39% | +350.59% | +646.53% | 4.41TCr | |
| -0.20% | -0.53% | +6.84% | +99.07% | 4.08TCr | |
| -0.54% | +2.93% | +9.50% | +50.41% | 3.08TCr | |
| -2.68% | +5.11% | +33.11% | +19.50% | 2.93TCr | |
| +2.33% | -8.58% | -24.55% | +340.08% | 2.37TCr | |
| Average | +0.03% | -0.64% | +53.40% | +154.55% | 3.93TCr | |
| Weighted average by Cap. | +0.25% | -0.40% | +58.36% | +145.81% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
